|
|
Details: |
|
|
Develops therapeutics based upon peptide analogs, primarily in regulation of glucose metabolism. Includes links for investors and patients, product pipeline, and career enquiries to San Diego, California. (Nasdaq: AMLN)
|
URL: |
http://www.amylin.com/
|
Title: |
Amylin |
Image: |
|
Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - Amylin Pharmaceuticals, Inc.. Develops therapeutics based upon peptide analogs, primarily in regulation of glucose metabolism. |
Similar: |
|
|
|
Related Sites |
|
Pharmos Corporation (Popularity: ): Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
ConjuChem, Inc. (Popularity: ): Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. ...
Connetics Corporation (Popularity: ): Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, ...
Generex Biotechnology (Popularity: ): Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
Lybradyn: Microbial Natural Products (Popularity: ): Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation ...
Morphochem (Popularity: ): Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Modular Genetics, Inc. (Popularity: ): Supporting basic research, drug design, drug screening and chemical synthesis.
Myogen, Inc. (Popularity: ): Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product ...
Virax Holdings, Ltd. (Popularity: ): Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. ...
EntreMed, Inc. (Popularity: ): Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
|
|
Popular Sites |
|
African Reptiles and Venom (Popularity: ): Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses ...
Aphios Corp. (Popularity: ): Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product ...
Bavarian Nordic (Popularity: ): Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV ...
Genfit (Popularity: ): Researching nuclear receptors and gene deregulation for treatment of cardiovascular, metabolic and inflammatory diseases. Includes information about genomic research.
BioMarin Pharmaceutical Inc. (Popularity: ): Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters ...
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Progeniq Joins Microsoft in Bio IT Alliance (Popularity: ): Microsoft Corp., announced the initiation of Progeniq Pte Ltd, a leader in reconfigurable computing applications headquartered in Singapore, into the ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
|
|
Related Articles |
|
|
|
|